Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching study

PURPOSE: We conducted a retrospective study to compare transarterial chemoembolization (TACE) plus lenvatinib plus programmed death-1 (PD-1) inhibitors with TACE plus lenvatinib in patients with unresectable hepatocellular carcinoma (HCC). PATIENTS AND METHODS: Patients with HCC were analyzed from J...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Peng, Pi, Xingtao, Gao, Feng, Li, Qiang, Li, Duqiang, Feng, Wendong, Cao, Wendong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630329/
https://www.ncbi.nlm.nih.gov/pubmed/36338683
http://dx.doi.org/10.3389/fonc.2022.945915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630329/
https://www.ncbi.nlm.nih.gov/pubmed/36338683
http://dx.doi.org/10.3389/fonc.2022.945915

Ejemplares similares